Induction of tumour rejection by autologous and allogeneic tumour cells expressing B7.1 and IL-2.

Induction of tumour rejection by autologous and allogeneic tumour cells expressing B7.1 and IL-2.

Bibliographic Details
Main Authors:	Hirst, W, Darling, D, Gaken, J, Buggins, A, Barnard, A, GaleaLauri, J, Kuiper, M, Hollignsworth, S, Mufti, G, Farzaneh, F
Format:	Journal article
Published:	1996

Similar Items

Induction of tumour rejection by B7.1 and IL-2 expressing tumour cells
by: Gaken, J, et al.
Published: (1997)

Tumour cells expressing B7.1 costimulatory molecule: Are these better targets for NK cells?
by: GaleaLauri, J, et al.
Published: (1996)

In vitro immune modulation by antibodies coupled to tumour cells.
by: Darling, D, et al.
Published: (1997)

Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors.
by: Gaken, J, et al.
Published: (1997)

A polycistronic retroviral vector encoding hB7-1 (CD80) and hIL-2 for ex vivo cancer gene therapy.
by: Kuiper, M, et al.
Published: (1996)

An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia.
by: Chan, L, et al.
Published: (2006)

IL-2/B7.1 fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: A strategy to generate whole cell vaccines for AML
by: Chan, L, et al.
Published: (2004)

IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
by: Chan, L, et al.
Published: (2005)

Dendritic cell/tumour fusions are more efficient at eliciting MHC class I-restricted Ag-specific CTL responses when compared to antigen-pulsed dendritic cells
by: Galea-Lauri, J, et al.
Published: (2001)

Low-speed centrifugation of retroviral vectors absorbed to a particulate substrate: a highly effective means of enhancing retroviral titre.
by: Darling, D, et al.
Published: (2000)

Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
by: Galea-Lauri, J, et al.
Published: (1999)

Novel costimulators in the immune gene therapy of cancer.
by: Galea-Lauri, J, et al.
Published: (1996)

Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells.
by: Chan, L, et al.
Published: (2005)

Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity.
by: Wells, J, et al.
Published: (2007)

Prospects of immune gene therapy for cancer
by: Hardwick, N, et al.
Published: (2004)

Tumour immune rejection triggered by activation of α2-adrenergic receptors
by: Zhu, J, et al.
Published: (2023)

Fas Ligand breaks tolerance to self antigens, induces tumour immunity and helps to generate tumour-rejecting monoclonal antibodies
by: Simon, A, et al.
Published: (2005)

Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination.
by: Galea-Lauri, J, et al.
Published: (2002)

Monocistronic high titre vectors for targeted expression of multiple therapeutic genes
by: Darling, D, et al.
Published: (2004)

High titre vectors for targeted expression of multiple genes
by: Darling, D, et al.
Published: (2004)

Surface enhanced deep Raman detection of cancer tumour through 71 mm of heterogeneous tissue
by: Dey, P, et al.
Published: (2022)

Harnessing the immune system to reject cancers through genetic modifications of tumour cells
by: Ajzensztejn, D
Published: (2015)

Fusagene vectors: A novel strategy for the expression of multiple genes from a single cistron
by: Gaken, J, et al.
Published: (1998)

Mesenchymal stem cells avoid allogeneic rejection
by: Murphy J Mary, et al.
Published: (2005-07-01)

Tumour markers in pediatric solid tumours
by: Singal A, et al.
Published: (2005-01-01)

Tumour volume distribution can yield information on tumour growth and tumour control
by: Uwe Schneider, et al.
Published: (2022-05-01)

Ultrasound morphological patterns of testicular tumours, correlation with histopathology
by: Martin Necas, et al.
Published: (2021-03-01)

Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron
by: Gaken, J, et al.
Published: (2001)

Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron.
by: Gäken, J, et al.
Published: (2000)

The Role of CDK5 in Tumours and Tumour Microenvironments
by: Phuong Anh Do, et al.
Published: (2020-12-01)

Generation of tumour-rejecting anti-carbohydrate monoclonal antibodies using melanoma modified with Fas ligand.
by: Simon, A, et al.
Published: (2008)

Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours
by: Kamilla JA. Bigos, et al.
Published: (2024-01-01)

Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma
by: Qin Tan, et al.
Published: (2019-08-01)

Safety and efficacy of autologous tumour cell vaccines as a cancer therapeutic to treat solid tumours and haematological malignancies: a meta-analysis protocol for two systematic reviews
by: Manoj Lalu, et al.
Published: (2020-06-01)

An epidemiological survey of tumour or tumour like conditions in the scapula and periscapular region
by: Khan Zeeshan, et al.
Published: (2016-01-01)

Radiotherapy in ocular tumours
by: Pinto J
Published: (1982-01-01)

Sclerostin expression in bone tumours and tumour-like lesions
by: Inagaki, Y, et al.
Published: (2016)

Tumour-associated macrophages: versatile players in the tumour microenvironment
by: Zoey Zeyuan Ji, et al.
Published: (2023-10-01)

The concurrent occurrence of neuroendocrine tumour and gastrointestinal stromal tumours
by: Divya Rathod, et al.
Published: (2022-10-01)

Maspin as a Tumour Suppressor in Salivary Gland Tumour
by: Bassel Tarakji, et al.
Published: (2014-12-01)